Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Several recent studies suggest that using NT-proBNP as a single biomarker for diagnosis of HF with HFpEF may not be sufficient. Is a combined biomarker strategy the path forward?
Tricuspid valve regurgitation has long been understudied and undertreated, but new studies are advancing our understanding of transcatheter tricuspid valve edge-to-edge repair for right-sided HF.
A new study confirms an association between chronic inflammatory disease, such as RA, and the development of incident HF. Do we need to broaden the spectrum of diseases considered Stage A HF?
August 21, 2020
Table of Contents
From JACC: Heart Failure
2021 -
9
(2)
Addressing Social Determinants of Health in the Evaluation of Heart Failure Therapies.
Mission Statement:
Aligned with the ACC's mission to transform cardiovascular care and improve heart health, the JACC Journals continuously strive to provide the best resources for cardiovascular investigators, clinicians, and specialists at every professional stage.
